Table 1.
Patient Characteristics at Baseline, by Pulmonary Exacerbations During Study
| No PE | Any PE | PE (No Hospitalization) | PE (Hospitalization) | |
|---|---|---|---|---|
| (n = 89) | (n = 72) | (n = 38) | (n = 34) | |
| Age, Mean (SD) | 25.5 (10.2) | 25.4 (8.8) | 28.3 (7.8) | 22.0 (8.7) |
| Female, N(%) | 41 (46.1 %) | 43 (59.7 %) | 20 (52.6 %) | 23 (67.6 %) |
| ppFEV1, Mean (SD) | 65.8 (15.8) | 60.8 (16.9) | 60.9 (16.3) | 60.6 (17.7) |
| BMI, N(%) | ||||
| Normal Weight | 75 (84.3 %) | 57 (79.2 %) | 28 (73.7 %) | 29 (85.3 %) |
| Obese | 3 (3.4 %) | 2 (2.8 %) | 2 (5.3 %) | 0 (0 %) |
| Overweight | 9 (10.1 %) | 8 (11.1 %) | 6 (15.8 %) | 2 (5.9 %) |
| Underweight | 2 (2.3 %) | 5 (6.9 %) | 2 (5.3 %) | 3 (8.8 %) |
| Sweat chloride, Mean (SD) | 100.5 (9.5) | 99.9 (11.3) | 100 (11.4) | 99.8 (11.2) |
| History of pancreatic insufficiency, N(%) | 81 (91.0 %) | 68 (94.4 %) | 35 (92.1 %) | 33 (97.1 %) |
| Use of inhaled cycling antibiotic, N(%) | 37 (41.6) | 19 (26.4 %) | 8 (21.1 %) | 11 (32.4 %) |